Virologic and Immunologic Effectiveness at 48 Weeks of Darunavir–Ritonavir-Based Regimens in Treatment-Experienced Persons Living with HIV-1 Infection in Clinical Practice

by Fernando Martín Biscione MD, PhD, Mateus Rodrigues Westin MD, PhD, Karina Mota Ribeiro MD, MSc, Denize Lotufo Estevam MD, Sandra Wagner Cardoso MD, MSc, Simone Barros Tenore MD, MSc, Lauro Ferreira da Silva Pinto Neto MD, PhD, Paulo Ricardo Alencastro MD, PhD, Theodoro Armando Suffert MD, Mônica Jacques de Moraes MD, PhD, Alexandre Naime Barbosa MD, PhD, Karen Mirna Loro Morejón MD, MSc, Érico Antônio Gomes de Arruda MD, PhD, Jussara María Silveira MD, PhD, José Luiz Andrade Neto MD, PhD, Dirceu Bartolomeu Greco MD, PhD, Unaí Tupinambás MD, PhD
Published 2014-01-01